Abstract
Sullivan et al. show that while many factors and cytokines contribute to primary immunosuppression, EV-associated IL-35 uniquely promotes “infectious” tolerance not only by inducing IL-35 production in non-Treg cells but also by causing an immunosuppressive phenotype in EV-acquiring T and B cells, leading to secondary suppression of immune responses.
Original language | English |
---|---|
Pages (from-to) | 1039-1051.e5 |
Journal | Cell Reports |
Volume | 30 |
Issue number | 4 |
DOIs | |
Publication status | Published - 2020 Jan 28 |
Bibliographical note
Funding Information:We wish to thank Dagna Sheerar and the personnel of the UW Carbone Cancer Center Flow Laboratory for technical support on flow cytometry and Image Stream experiments. We also acknowledge the support of Dr. Anita Chong and Dr. Marisa Alegre and their labs at the University of Chicago for providing splenocytes from BALB/c × C57BL/6 [Tg for mOVA-2W1S] mice for tolerization studies and Scott Burlingham for discussion and suggestions. This project was supported by the NIH (grant R01-AI119140-03 to W.J.B., R03-144-AAH5568 to J.A.S. and grants R01 CA203689 and P30 CA047904 to D.A.A.V.) and University of Wisconsin Carbone Cancer Center (support grant P30 CA014520 ).
Funding Information:
We wish to thank Dagna Sheerar and the personnel of the UW Carbone Cancer Center Flow Laboratory for technical support on flow cytometry and Image Stream experiments. We also acknowledge the support of Dr. Anita Chong and Dr. Marisa Alegre and their labs at the University of Chicago for providing splenocytes from BALB/c ? C57BL/6 [Tg for mOVA-2W1S] mice for tolerization studies and Scott Burlingham for discussion and suggestions. This project was supported by the NIH (grant R01-AI119140-03 to W.J.B. R03-144-AAH5568 to J.A.S. and grants R01 CA203689 and P30 CA047904 to D.A.A.V.) and University of Wisconsin Carbone Cancer Center (support grant P30 CA014520). Conceptualization, J.A.S. D.A.A.V. W.J.B. and E.J.-G.; Methodology, J.A.S. Y.T. D.A.L. E.J.-G. W.B.-B. W.Z. D.W.S. A.L.S.-W. Q.Z. K.K.M. C.J.W. and S.H.; Investigation, J.A.S. W.J.B. E.J.-G. A.N. D.A.L. M.P.A. and Y.T.; Writing ? Original Draft, J.A.S. W.J.B. E.J.G. Y.T. and D.A.A.V.; Writing ? Review & Editing, J.A.S. E.J.G. D.A.A.V. C.J.W. M.P.A. and W.J.B.; Funding Acquisition, W.J.B. and D.A.A.V.; Resources, D.A.A.V. W.J.B. and S.H.; Supervision, J.A.S. D.A.A.V. S.H. and W.J.B. The authors declare no competing interests.
Publisher Copyright:
© 2019 The Author(s)
All Science Journal Classification (ASJC) codes
- Biochemistry, Genetics and Molecular Biology(all)